Valuation: Inogen, Inc.

Market Cap 140M 124M 116M 106M 199M 13.47B 202M 1.4B 544M 6.87B 525M 514M 22.11B P/E 2026 *
-6.89x
P/E 2027 * -11.1x
Enterprise Value 140M 124M 116M 106M 199M 13.47B 202M 1.4B 544M 6.87B 525M 514M 22.11B EV / Sales 2026 *
0.39x
EV / Sales 2027 * 0.38x
Free-Float
87.05%
Yield 2026 *
-
Yield 2027 * -
1 day+13.47%
1 week+17.49%
Current month+13.47%
1 month+11.36%
3 months-7.29%
6 months-3.24%
Current year-11.01%
1 week 5.2
Extreme 5.2
6.16
1 month 5.04
Extreme 5.045
6.16
Current year 5.04
Extreme 5.045
7.67
1 year 5.04
Extreme 5.045
9.13
3 years 4.13
Extreme 4.13
13.33
5 years 4.13
Extreme 4.13
44.3
10 years 4.13
Extreme 4.13
287.79
Manager TitleAgeSince
Chief Executive Officer 55 10/11/2023
Director of Finance/CFO 48 06/04/2026
Chief Operating Officer 56 06/07/2026
Director TitleAgeSince
Director/Board Member 66 06/08/2014
Chairman 65 29/12/2021
Director/Board Member 59 22/03/2022
Date Insider Type Main position Quantity % Market Cap. Importance
9/1/26 A Free

Controller/Auditor

1,500 0.0057%
9/1/26 A Free

General Counsel

46,443 0.1750%
9/1/26 A Free

Chief Executive Officer

1,500 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+13.47%+17.49%-26.81%+14.56% 140M
-2.17%-6.57%-27.81%-0.17% 171B
+0.17%-3.20%-9.24%+10.31% 110B
-0.88%-0.16%-26.16%-0.11% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.80%-0.88%+72.13% 57.3B
-0.52%-2.44%-4.86%-31.12% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%-0.82%-18.96%+18.41% 41.14B
-0.07%-1.71%+28.15%-7.58% 32.56B
Average +1.46%-0.96%-11.51%+12.31% 69.31B
Weighted average by Cap. -0.38%-2.07%-16.38%+9.02%

Financials

2026 *2027 *
Net sales 356M 317M 296M 270M 507M 34.32B 514M 3.58B 1.39B 17.5B 1.34B 1.31B 56.34B 373M 331M 310M 282M 530M 35.89B 538M 3.74B 1.45B 18.29B 1.4B 1.37B 58.9B
Net income -20.8M -18.5M -17.29M -15.76M -29.57M -2B -30.03M -209M -80.88M -1.02B -78.09M -76.39M -3.29B -13.35M -11.87M -11.09M -10.12M -18.98M -1.29B -19.27M -134M -51.91M -655M -50.12M -49.03M -2.11B
Net Debt - -
Logo Inogen, Inc.
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.
Employees
753
Date Price Change Volume
01/10/26 $5.980 +13.47% 1,104,873
30/09/26 $5.270 -1.86% 267,486
29/09/26 $5.370 -1.29% 231,991
28/09/26 $5.440 +1.49% 301,882
25/09/26 $5.360 +2.49% 615,379
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.980USD
Average target price
12.00USD
Spread / Average Target
+100.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INGN Stock